EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2025 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2025 Earnings Call Transcript March 4, 2026EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cormorant Asset Management Bihua Chen | 8,265,000 | $151,001,550 | -1% | 6.98% |
| 2. | Suvretta Capital Management Aaron Cowen | 7,827,685 | $143,011,805 | +27% | 2.93% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 4,700,000 | $85,869,000 | -16% | 0.13% |
| 4. | Paradigm Biocapital Advisors Senai Asefaw | 3,691,475 | $67,443,248 | +85% | 1.72% |
| 5. | OrbiMed Advisors Samuel Isaly | 2,468,314 | $45,096,097 | +38% | 0.92% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.15 | 1,500 | $19,723.80 | 100,665 | 2026-03-16 | Filing | |
| $5.99 | 5,000 | $29,950.00 | 36,500 | 2025-05-19 | Filing | |
| $5.81 | 5,000 | $29,050.00 | 31,500 | 2025-05-16 | Filing | |
| $5.47 | 5,000 | $27,350.00 | 26,500 | 2025-05-15 | Filing | |
| $5.42 | 5,000 | $27,100.00 | 21,500 | 2025-05-14 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.87 | 2,438 | $43,571.69 | 0 | 2026-03-04 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-02-17 | Filing | |
| $17.10 | 42,544 | $727,319.46 | 0 | 2026-01-05 | Filing | |
| $15.70 | 60,000 | $942,240.00 | 8,265,000 | 2025-12-04 | Filing | |
| $15.11 | 9,300 | $140,477.43 | 206,547 | 2025-12-04 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,787,872 | $124,014,422 | 0% | |
| 2. | 6,017,433 | $109,938,500 | 0.18% | |
| 3. | 4,976,915 | $90,928,238 | 0.02% | |
| 4. | 4,822,139 | $88,100,480 | 0% | |
| 5. | 3,572,335 | $65,266,560 | 2.16% |